Effect of Cold Shower Therapy on Hot Flashes And Night Sweats in Menopausal Women
1 other identifier
interventional
60
1 country
1
Brief Summary
This randomized controlled trial aims to evaluate the effect of a 6-week cold shower therapy on hot flashes and night sweats in menopausal women. Participants will be randomly assigned to either a cold shower therapy group or a control group. The primary outcome is the change in the frequency and severity of hot flashes and night sweats after the 6-week intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 30, 2026
CompletedFirst Submitted
Initial submission to the registry
July 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 7, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 7, 2026
CompletedFirst Posted
Study publicly available on registry
July 10, 2026
CompletedJuly 10, 2026
July 1, 2026
5 months
July 6, 2026
July 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Hot Flash and Night Sweat Frequency and Severity
Change in the frequency and severity of hot flashes and night sweats measured at baseline, week 3 and week 6.
Baseline, Week 3, Week 6
Study Arms (2)
Cold Shower Therapy
EXPERIMENTALParticipants received cold shower therapy for 6 weeks.
Control
NO INTERVENTIONParticipants received routine care and no cold shower therapy during the study period.
Interventions
Participants in the intervention group received daily cold shower therapy for 6 weeks. Water temperature was maintained at 15-20°C using a thermometer provided to participants. The control group received routine care without cold shower therapy. Outcomes were assessed at baseline and after 6 weeks.
Eligibility Criteria
You may qualify if:
- Able to read, write, and understand the study procedures.
- Women aged 40-65 years.
- Postmenopausal women experiencing hot flashes and/or night sweats.
- Not receiving hormone replacement therapy (HRT) for vasomotor symptoms.
- No known medical contraindication to cold shower therapy.
- Willing to participate and able to provide written informed consent.
You may not qualify if:
- History of serious chronic diseases that may affect hemodynamic stability (e.g., cardiovascular disease, uncontrolled hypertension, renal failure, or liver failure).
- Current use of antidepressant or antipsychotic medications, or diagnosis of a severe psychiatric disorder.
- Regular use of cold shower or cold-water therapy before enrollment.
- Incomplete completion of study questionnaires or data collection forms
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Buyukada Central Family Health Center, Unit 001
Istanbul, Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nuran Gencturk, PhD
Istanbul University - Cerrahpasa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Istanbul University - Cerrahpasa
Study Record Dates
First Submitted
July 6, 2026
First Posted
July 10, 2026
Study Start
January 30, 2026
Primary Completion
July 7, 2026
Study Completion
July 7, 2026
Last Updated
July 10, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share